0001209191-20-008870.txt : 20200212 0001209191-20-008870.hdr.sgml : 20200212 20200212171455 ACCESSION NUMBER: 0001209191-20-008870 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200210 FILED AS OF DATE: 20200212 DATE AS OF CHANGE: 20200212 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Lee Yuchun CENTRAL INDEX KEY: 0001334365 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19319 FILM NUMBER: 20605398 MAIL ADDRESS: STREET 1: 170 TRACER LA. CITY: WALTHAM STATE: MA ZIP: 02451 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA CENTRAL INDEX KEY: 0000875320 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 043039129 STATE OF INCORPORATION: MA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 50 NORTHERN AVENUE CITY: BOSTON STATE: MA ZIP: 02210 BUSINESS PHONE: 6173416393 MAIL ADDRESS: STREET 1: 50 NORTHERN AVENUE CITY: BOSTON STATE: MA ZIP: 02210 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-02-10 0 0000875320 VERTEX PHARMACEUTICALS INC / MA VRTX 0001334365 Lee Yuchun C/O VERTEX PHARMACEUTICALS INCORPORATED 50 NORTHERN AVENUE BOSTON MA 02210 1 0 0 0 Common Stock 2020-02-10 4 M 0 1181 57.27 A 3056 D Common Stock 2020-02-10 4 S 0 120 240.04 D 2936 D Common Stock 2020-02-10 4 S 0 360 241.61 D 2576 D Common Stock 2020-02-10 4 S 0 360 242.86 D 2216 D Common Stock 2020-02-10 4 S 0 229 243.55 D 1987 D Common Stock 2020-02-10 4 S 0 112 244.79 D 1875 D Stock Options (Right to Buy) 57.27 2020-02-10 4 M 0 1181 0.00 D 2022-09-13 Common Stock 1181 13125 D Transaction made pursuant to Mr. Lee's company approved trading plan under Rule 10b5-1. Open market sales reported on this line occurred at a weighted average price of $240.04 (range $239.59 to $240.49). Mr. Lee undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. Open market sales reported on this line occurred at a weighted average price of $241.61 (range $241.26 to $241.87). Open market sales reported on this line occurred at a weighted average price of $242.86 (range $242.37 to $243.36). Open market sales reported on this line occurred at a weighted average price of $243.55 (range $243.46 to $243.72). Open market sales reported on this line occurred at a weighted average price of $244.79 (range $244.78 to $244.84). Fully vested. /s/ Omar White, Attorney-in-Fact 2020-02-12